FertiCare SE
- Address
- lock Available on a paid plan
Female Urogenital Health and Pregnancy-Related Research
At FertiCare SE in Prague, clinical trial activity focuses on Female Urogenital Diseases and Pregnancy Complications, with a clear emphasis on infertility in women undergoing assisted reproductive technologies. The research is aimed at understanding how new treatment approaches may support fertility care and improve outcomes for women receiving reproductive treatment.
- Female urogenital diseases and fertility-related conditions
- Infertility in women receiving assisted reproductive technologies
- Evaluating a new therapy approach to support controlled ovarian stimulation
These studies are designed to explore treatment effectiveness and help refine care for women undergoing fertility treatment, contributing to better reproductive medicine practice at this research site.
Assisted Reproductive Medicine Studies
The trials at FertiCare SE examine clinical approaches within reproductive medicine, especially for women undergoing controlled ovarian stimulation as part of fertility treatment. The main goal is to assess whether a new investigational therapy may improve support during the stimulation process and enhance the overall treatment experience.
- Infertility treatment in women
- Assisted reproductive technologies and ovarian stimulation care
- Testing a potential treatment to improve fertility-related outcomes
With a small but focused portfolio, the site contributes to research that may help advance more effective and patient-centered options in reproductive healthcare.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ferring Pharmaceuticals A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in FertiCare SE
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Exploratory Study on the Effects of FE 999302 During Controlled Ovarian Stimulation with Follitropin Delta in Women Undergoing ART for Infertility | Ferring Pharmaceuticals A/S | Phase I | Not Recruiting | Jul 2024 | Sep 2025 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.